European consortium to develop a new generation cell therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

European (EU) H2020 funded VANGUARD project is set to generate a tissue engineered bioartificial pancreas, which, due to its high translation potential, meets all the criteria for the next stage from bench to bedside. The developed beta cell replacement therapy will be available to larger numbers of type 1 diabetic patients.